» Articles » PMID: 18441017

An Apolipoprotein A-V Gene SNP is Associated with Marked Hypertriglyceridemia Among Asian-American Patients

Abstract

Apolipoprotein A-V (apoA-V) is an important regulator of plasma levels of triglyceride (TG) in mice. In humans, APOA5 genetic variation is associated with TG in several populations. In this study, we determined the effects of the p.185Gly>Cys (c.553G>T; rs2075291) polymorphism on plasma TG levels in subjects of Chinese ancestry living in the United States and in a group of non-Chinese Asian ancestry. The frequency of the less common cysteine allele was 4-fold higher (15.1% vs. 3.7%) in Chinese high-TG subjects compared with a low-TG group (Chi-square = 20.2; P < 0.0001), corresponding with a 4.45 times higher risk of hypertriglyceridemia (95% confidence interval, 2.18-9.07; P < 0.001). These results were replicated in the non-Chinese Asians. Heterozygosity was associated, in the high-TG group, with a doubling of TG (P < 0.001), mainly VLDL TG (P = 0.014). All eleven TT homozygotes had severe hypertriglyceridemia, with mean TG of 2,292 +/- 447 mg/dl. Compared with controls, carriers of the T allele had lower postheparin lipoprotein lipase activity but not hepatic lipase activity. In Asian populations, this common polymorphism can lead to profound adverse effects on lipoprotein profiles, with homozygosity accounting for a significant number of cases of severe hypertriglyceridemia. This specific apoA-V variant has a pronounced effect on TG metabolism, the mechanism of which remains to be elucidated.

Citing Articles

Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease.

Zhang J, Tang Z, Jiang J, Huang S, Zeng H, Gu J Rev Cardiovasc Med. 2024; 24(11):314.

PMID: 39076452 PMC: 11272848. DOI: 10.31083/j.rcm2411314.


APOA5 deficiency causes hypertriglyceridemia by reducing amounts of lipoprotein lipase in capillaries.

Yang Y, Konrad R, Ploug M, Young S J Lipid Res. 2024; 65(7):100578.

PMID: 38880127 PMC: 11299584. DOI: 10.1016/j.jlr.2024.100578.


Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.

Chen Y, Yang Y, Zhen E, Beyer T, Li H, Wen Y Proc Natl Acad Sci U S A. 2024; 121(17):e2322332121.

PMID: 38625948 PMC: 11046700. DOI: 10.1073/pnas.2322332121.


Risk Variants Associate With the Prevalence of Stroke in African American Current and Past Smokers.

Rakic J, Pullinger C, Van Blarigan E, Movsesyan I, Stock E, Malloy M J Am Heart Assoc. 2023; 12(24):e030796.

PMID: 38084718 PMC: 10863786. DOI: 10.1161/JAHA.123.030796.


Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen.

Yang Y, Beigneux A, Song W, Nguyen L, Jung H, Tu Y J Clin Invest. 2023; 133(23).

PMID: 37824203 PMC: 10688983. DOI: 10.1172/JCI172600.


References
1.
Miida T, Seino U, Miyazaki O, Hanyu O, Hirayama S, Saito T . Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling. Atherosclerosis. 2008; 200(2):329-35. DOI: 10.1016/j.atherosclerosis.2007.12.031. View

2.
Pennacchio L, Olivier M, Hubacek J, Cohen J, Cox D, Fruchart J . An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001; 294(5540):169-73. DOI: 10.1126/science.1064852. View

3.
Talmud P, Hawe E, Martin S, Olivier M, Miller G, Rubin E . Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet. 2002; 11(24):3039-46. DOI: 10.1093/hmg/11.24.3039. View

4.
Brunzell J . Clinical practice. Hypertriglyceridemia. N Engl J Med. 2007; 357(10):1009-17. DOI: 10.1056/NEJMcp070061. View

5.
Lookene A, Beckstead J, Nilsson S, Olivecrona G, Ryan R . Apolipoprotein A-V-heparin interactions: implications for plasma lipoprotein metabolism. J Biol Chem. 2005; 280(27):25383-7. DOI: 10.1074/jbc.M501589200. View